| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |